News Announcement

Strides Pharma Science: Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)

Strides Pharma Inc receives USFDA closure report (EIR) for its formulations facility at Chestnut Ridge New YorkInspection included Drug Device Combinations covering our recent filing in Nasal Sprays domain

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.